Lyra Therapeutics, Inc. (LYRA)
OTCMKTS · Delayed Price · Currency is USD
0.1900
-0.0050 (-2.56%)
At close: Oct 9, 2026
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $337.23 thousand as of October 9, 2026. It is the 50,676th most valuable company in the world and the 7,053rd biggest in the United States. Its market cap has decreased by 97.34% in one year.
Market Cap
337.23K
Enterprise Value
14.70M
Revenue
398.00K
Global Rank
Country Rank
#7,053 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from 230.14M to 337.23K, a decrease of -99.85%. That is a compound annual growth rate of -63.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 337.23K | -93.83% |
| Dec 31, 2025 | 5.47M | -59.54% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CERo Therapeutics Holdings | 675.70K |
| ZyVersa Therapeutics | 646.66K |
| Sorrento Therapeutics | 434.97K |
| Actavia Life Sciences | 385.91K |
| CNBX Pharmaceuticals | 385.15K |
| MetaStat | 319.73K |
| Altamira Therapeutics | 314.92K |
| Zenith Capital | 257.79K |